NYS DOH STD Reporting Form

Total Page:16

File Type:pdf, Size:1020Kb

NYS DOH STD Reporting Form To order more copies of this form call the Provider Access Line: 1-866-NYC-DOH1 NYC Department of Health & Mental Hygiene Universal Reporting Form PHA No. Form PD-16 (9/09) Mail completed form to: NYC Dept. of Health & Mental Hygiene; 125 Worth Street, Room 315, CN-6; New York, NY 10013 • Or report online: www.nyc.gov/nycmed P Patient Last Name First Name Middle Name DATE OF REPORT A T Patient AKA: Last Name AKA: First Name M.I . I ____ / ____ / ____ E Date of Birth Age Country of Birth Soc.Sec.No. N T ____ / ____ / ________ If patient is a child, Guardian Last Name Guardian First Name M.I. Ⅺ Homeless I Borough: Manhattan N Patient Home Address Apt. No. Zip Code Bronx F Unknown Brooklyn O Home Telephone Number Medical Record Number ( _______ ) ________ – _____________ Queens R Unknown M Staten Island Other Telephone Number Medicaid Number Ⅺ NYC, borough unknown A Unknown ( _______ ) ________ – _____________ Unknown T Ⅺ I Sex Race (Check all that apply) Ethnicity Hispanic Please report non-NYC Not NYC (Specify City/State) Male Transexual Asian White American Indian/Alaska Native Unknown (Check one) Non-Hispanic residents to the appropriate ________________, _____ O N Female Unknown Black Other race Native Hawaiian/Pacific Islander Unknown health jurisdiction Ⅺ Unknown Admitted to hospital? Admission Date Is patient alive? If no, date of death Unknown Is patient pregnant? If yes, due date Yes No ____ / ____ / ________ Unknown Yes No Yes No Unknown Discharge Date Unknown ____ / ____ / ________ Unknown Unknown _____ / _____ / ________ Unknown ____ / ____ / ______ DATE OF DIAGNOSIS Risk Groups for Disease Exposure and/or Transmission Unknown ____ / ____ / _______ Patient works in: Childcare Food service Health care Nursing home Other _________________________________________ Ⅺ DATE OF ILLNESS ONSET Attends/resides in: Nursing home Day Care/Group baby-sit Homeless shelter Correctional facility School Hospital Other _____________ Unknown ____ / ____ / _______ Foreign travel: Countries ____________________________________________________ Date returned to U.S. __ __ / __ __ / __ __ Name of Person Reporting Disease Phone REPORTER INFORMATION Number ( _______ ) ________ – _____________ Facility of Person Reporting Disease PFI Code Street Address City State Zip Code Name of Hospital/Healthcare Facility PFI Code Phone Unknown ( _______ ) ________ – _____________ Street Address City State Zip Code Name of Testing Laboratory PFI Code Phone Unknown Unknown Unknown ( _______ ) ________ – _____________ Street Address City State Zip Code Unknown Unknown Unknown Unknown Name of Physician Phone Unknown Unknown ( _______ ) ________ – _____________ Street Address City State Zip Code Unknown Unknown Unknown Unknown Call DOHMH if there is an outbreak or suspected outbreak of any disease or condition, of known or unknown etiology occurring in three or more persons or any unusual manifestation of a disease in an individual. Call Provider Access Line 1-866-NYC-DOH1; after hours, call Poison Control Center 1-212-Poisons (764-7667) Comments (Additional space on Page 4) Page 1 Patient Last Name First Name Medical Record Number DISEASE WITH SPECIAL INSTRUCTIONS Ⅺ Amebiasis (Entamoeba histolytica only Ⅺ Ehrlichiosis, Human monocytic ehrlichiosis Herpes, Neonatal: see STD section, page 3 Ⅺ Salmonellosis ** Serogroup: _______ or cases in which E. histolytica cannot be If human granulocytic anaplasmosis report as anaplasmosis. If due to Salmonella typhi or paratyphi, distinguished from Entamoeba dispar.) ** Ⅺ Encephalitis HIV/AIDS. For assistance in reporting a case of select Typhoid/Paratyphoid Fever Ⅺ Anaplasmosis Jul.1–Oct. 31 consider and test for West Nile virus. HIV/AIDS, to receive the required New York State Ⅺ SARS (Severe Acute Respiratory Syndrome) * Formerly human granulocytic ehrlichiosis If due to another reportable disease (e.g. Lyme, West Nile, Provider Report Forms (PRF), or to obtain more Ⅺ Shigellosis ** arbovirus), report under the other disease. information, call (212) 442-3388. Ⅺ Animal Bites (please fill out animal bite information below) Ⅺ Smallpox * ࠗ Exposure to rabies * Ⅺ Escherichia coli O157:H7 ** Ⅺ Influenza Check all that apply: Ⅺ Staph Enterotoxin B * Including a bite or other exposure (e.g, scratch) to any Ⅺ Escherichia coli (other) Shiga Toxin Producing ** ࠗ Suspected novel viral strain with pandemic potential Ⅺ Staphylococcus aureus, vancomycin intermediate animal confirmed to have rabies, or from any rabies (e.g. H5) * and resistant * vector species (raccoon, bat, skunk, fox or coyote), or Ⅺ Giardiasis ** any mammal exhibiting signs suggestive of rabies. ࠗ Death in a child younger than 18 years of age Source: ____________________ Ⅺ Glanders * Ⅺ Animal Species: _____________________ Kawasaki Syndrome MIC (μg/ml): _________________ Gonorrhea: see STD section, page 3 Breed: __________________________ Granuloma Inguinale: see STD section, page 3 Ⅺ Legionellosis, Specify positive test: Ⅺ Streptococcus (Group A) Invasive only Color(s): _________________________ ࠗ Culture ࠗ Urine antigen ࠗ ࠗ ࠗ Ⅺ Hantavirus * Specify Source: Blood CSF Unknown Date of Bite: ____ / ____ / ____ ࠗ DFA ࠗ Serology ࠗ Other, Specify: ___________________ Ⅺ Hemolytic Uremic Syndrome Area of body bitten __________________ Ⅺ Leprosy (Hansen’s Disease) Ⅺ Streptococcus (Group B) Invasive only Ⅺ Hemophilus influenzae, invasive only Activity at time of bite ________________ Ⅺ Specify Source: ࠗ Blood ࠗ CSF ࠗ Unknown Specimen Source: Leptospirosis Place of occurrence __________________ ࠗ Other, Specify: ___________________ ࠗ Blood ࠗ CSF ࠗ Unknown Ⅺ Listeriosis Treatment given: ___________________ ࠗ Other_______________________ Ⅺ Lyme Disease Syphilis: see STD section, page 3 Rabies prophylaxis ࠗ Yes ࠗ No Specify Serotype: Erythema migrans present? ࠗ ࠗ ࠗ ࠗ ࠗ Ⅺ HRIG ࠗ Yes ࠗ No Type B Not typeable Yes No Unknown Tetanus ࠗ ࠗ ࠗ ࠗ Not tested Unknown Ⅺ Rabies Vaccine Yes No Ⅺ Lymphocytic Choriomeningitis Virus Toxic shock syndrome, For staph only. ࠗ Other_______________________ Animal ࠗ Owned ࠗ Stray ࠗ Unknown For strep select Streptococcus (Group A). Ⅺ Animal’s owner (last name, first name): Lymphogranuloma Venereum: see STD section on Page 3 Trachoma ______________________________ Ⅺ Transmissible Spongiform Encephalopathy Ⅺ Address (Street, Apt.): FOR ALL HEPATITIS REPORTS: Malaria ** Select at least one of the following: Creutzfeld-Jakob Disease and variants ࠗ falciparum ࠗ vivax ࠗ malariae Testing done: ______________________ ______________________________ Jaundice ࠗ Yes ࠗ No ࠗ Unknown ࠗ ovale ࠗ undetermined (e.g. 14-3-3 on CSF, brain biopsy, autopsy, EEG/MRI) Boro/City, State, Zip: ALT (SGPT) value: _____________⅜ Unknown Ⅺ ______________________________ Lab reference range: ___________⅜ Unknown Measles * Ⅺ Trichinosis: Caused by bacterium Trichinella Ⅺ Telephone Number: Melioidosis * spiralis. (Trichomoniasis, caused by Trichomonas vaginalis, need not be reported.) ( ______ ) ______ – _____________ Ⅺ Hepatitis A */** Ⅺ Meningitis, Aseptic/Viral Tuberculosis: see TB section on page 4 Ⅺ Anthrax * Total Ab to Hepatitis A is NOT reportable Jul.1–Oct. 31 consider and test for West Nile virus. Ⅺ Arboviral Infections * IgM anti-HAV: ࠗ Pos ࠗ Neg ࠗ Unknown If due to another reportable disease (e.g. Lyme, West Nile, Ⅺ Tularemia * arbovirus), report under the other disease. Specify which virus: __________________ Ⅺ Typhoid /Paratyphoid Fever ** Ⅺ Hepatitis B If Dengue, West Nile or Yellow Fever, report as such. Ⅺ Meningitis, other bacterial Report at least one positive hepatitis B test result: Ⅺ Attach copies of diagnostic laboratory results if available. Specify Organism: ___________________ Vaccinia disease (adverse events associated with Ⅺ Total Ab to Hepatitis B is NOT reportable smallpox vaccination) * Babesiosis Ⅺ Babesiosis can be transmitted through blood products. If IgM anti-HBc ࠗ Pos ࠗ Neg ࠗ Unknown Meningococcal Disease, Invasive * Ⅺ Vibrio spp. * patient has a history of receiving blood transfusion or If positive, describe symptoms and risks in Test type/Specimen source: Specify species: ____________________ donating blood within 3 months of onset of illness, report ࠗ ࠗ comments box on page 1 and indicate sexual part- Blood culture CSF Culture Ⅺ Viral Hemorrhagic Fever * suspected/confirmed cases immediately.* ࠗ Antigen test from CSF ࠗ Gram stain Ⅺ ners in the past year (Check only one) Botulism * ࠗ Other________________________ Ⅺ West Nile Virus * Attach copies of diagnostic labora- ࠗ Males only ࠗ Females only ࠗ Foodborne ࠗ Wound ࠗ Infant tory results if available ࠗ Males and Females ࠗ Unknown Ⅺ Brucellosis * Ⅺ Monkeypox * ࠗ ࠗ ࠗ Ⅺ Window Falls. Ⅺ Campylobacteriosis ** HBsAg: Pos Neg Unknown Mumps HBeAg: ࠗ Pos ࠗ Neg ࠗ Unknown Falls from windows of buildings with three or more Chancroid: see STD section, page 3 Ⅺ apartments, by children aged ten years and younger, HBV Nucleic Acid: ࠗ Pos ࠗ Neg ࠗ Unknown Pertussis for hospitalized cases* Chlamydia: see STD section, page 3 report on yellow Child Window Fall Notification Ⅺ Ⅺ Plague * Cholera */** Cases in pregnant women must be reported on the IMM5 or via Report. For assistance call 1-866-NYC-DOH1 Ⅺ Creutzfeld-Jakob Disease: see Transmissible Reporting Central. For information call 718-520-8245. Poisoning: see Poisoning section, page 3 Spongiform Encephalopathy Ⅺ Polio * Ⅺ Yellow Fever * Attach copies of diagnostic labora- Ⅺ Hepatitis C Ⅺ Cryptosporidiosis ** Ⅺ tory results if available Check all that apply: Psittacosis Ⅺ Cyclospora ** Ⅺ Yersiniosis **
Recommended publications
  • Reporting of Diseases and Conditions Regulation, Amendment, M.R. 289/2014
    THE PUBLIC HEALTH ACT LOI SUR LA SANTÉ PUBLIQUE (C.C.S.M. c. P210) (c. P210 de la C.P.L.M.) Reporting of Diseases and Conditions Règlement modifiant le Règlement sur la Regulation, amendment déclaration de maladies et d'affections Regulation 289/2014 Règlement 289/2014 Registered December 23, 2014 Date d'enregistrement : le 23 décembre 2014 Manitoba Regulation 37/2009 amended Modification du R.M. 37/2009 1 The Reporting of Diseases and 1 Le présent règlement modifie le Conditions Regulation , Manitoba Règlement sur la déclaration de maladies et Regulation 37/2009, is amended by this d'affections , R.M. 37/2009. regulation. 2 Schedules A and B are replaced with 2 Les annexes A et B sont remplacées Schedules A and B to this regulation. par les annexes A et B du présent règlement. Coming into force Entrée en vigueur 3 This regulation comes into force on 3 Le présent règlement entre en vigueur January 1, 2015, or on the day it is registered le 1 er janvier 2015 ou à la date de son under The Statutes and Regulations Act , enregistrement en vertu de Loi sur les textes whichever is later. législatifs et réglementaires , si cette date est postérieure. December 19, 2014 Minister of Health/La ministre de la Santé, 19 décembre 2014 Sharon Blady 1 SCHEDULE A (Section 1) 1 The following diseases are diseases requiring contact notification in accordance with the disease-specific protocol. Common name Scientific or technical name of disease or its infectious agent Chancroid Haemophilus ducreyi Chlamydia Chlamydia trachomatis (including Lymphogranuloma venereum (LGV) serovars) Gonorrhea Neisseria gonorrhoeae HIV Human immunodeficiency virus Syphilis Treponema pallidum subspecies pallidum Tuberculosis Mycobacterium tuberculosis Mycobacterium africanum Mycobacterium canetti Mycobacterium caprae Mycobacterium microti Mycobacterium pinnipedii Mycobacterium bovis (excluding M.
    [Show full text]
  • Syphilis Staging and Treatment Syphilis Is a Sexually Transmitted Disease (STD) Caused by the Treponema Pallidum Bacterium
    Increasing Early Syphilis Cases in Illinois – Syphilis Staging and Treatment Syphilis is a sexually transmitted disease (STD) caused by the Treponema pallidum bacterium. Syphilis can be separated into four different stages: primary, secondary, early latent, and late latent. Ocular and neurologic involvement may occur during any stage of syphilis. During the incubation period (time from exposure to clinical onset) there are no signs or symptoms of syphilis, and the individual is not infectious. Incubation can last from 10 to 90 days with an average incubation period of 21 days. During this period, the serologic testing for syphilis will be non-reactive but known contacts to early syphilis (that have been exposed within the past 90 days) should be preventatively treated. Syphilis Stages Primary 710 (CDC DX Code) Patient is most infectious Chancre (sore) must be present. It is usually marked by the appearance of a single sore, but multiple sores are common. Chancre appears at the spot where syphilis entered the body and is usually firm, round, small, and painless. The chancre lasts three to six weeks and will heal without treatment. Without medical attention the infection progresses to the secondary stage. Secondary 720 Patient is infectious This stage typically begins with a skin rash and mucous membrane lesions. The rash may manifest as rough, red, or reddish brown spots on the palms of the hands, soles of the feet, and/or torso and extremities. The rash does usually does not cause itching. Rashes associated with secondary syphilis can appear as the chancre is healing or several weeks after the chancre has healed.
    [Show full text]
  • Disseminated Mycobacterium Tuberculosis with Ulceronecrotic Cutaneous Disease Presenting As Cellulitis Kelly L
    Lehigh Valley Health Network LVHN Scholarly Works Department of Medicine Disseminated Mycobacterium Tuberculosis with Ulceronecrotic Cutaneous Disease Presenting as Cellulitis Kelly L. Reed DO Lehigh Valley Health Network, [email protected] Nektarios I. Lountzis MD Lehigh Valley Health Network, [email protected] Follow this and additional works at: http://scholarlyworks.lvhn.org/medicine Part of the Dermatology Commons, and the Medical Sciences Commons Published In/Presented At Reed, K., Lountzis, N. (2015, April 24). Disseminated Mycobacterium Tuberculosis with Ulceronecrotic Cutaneous Disease Presenting as Cellulitis. Poster presented at: Atlantic Dermatological Conference, Philadelphia, PA. This Poster is brought to you for free and open access by LVHN Scholarly Works. It has been accepted for inclusion in LVHN Scholarly Works by an authorized administrator. For more information, please contact [email protected]. Disseminated Mycobacterium Tuberculosis with Ulceronecrotic Cutaneous Disease Presenting as Cellulitis Kelly L. Reed, DO and Nektarios Lountzis, MD Lehigh Valley Health Network, Allentown, Pennsylvania Case Presentation: Discussion: Patient: 83 year-old Hispanic female Cutaneous tuberculosis (CTB) was first described in the literature in 1826 by Laennec and has since been History of Present Illness: The patient presented to the hospital for chest pain and shortness of breath and was treated for an NSTEMI. She was noted reported to manifest in a variety of clinical presentations. The most common cause is infection with the to have redness and swelling involving the right lower extremity she admitted to having for 5 months, which had not responded to multiple courses of antibiotics. She acid-fast bacillus Mycobacterium tuberculosis via either primary exogenous inoculation (direct implantation resided in Puerto Rico but recently moved to the area to be closer to her children.
    [Show full text]
  • Pdf/Bookshelf NBK368467.Pdf
    BMJ 2019;365:l4159 doi: 10.1136/bmj.l4159 (Published 28 June 2019) Page 1 of 11 Practice BMJ: first published as 10.1136/bmj.l4159 on 28 June 2019. Downloaded from PRACTICE CLINICAL UPDATES Syphilis OPEN ACCESS Patrick O'Byrne associate professor, nurse practitioner 1 2, Paul MacPherson infectious disease specialist 3 1School of Nursing, University of Ottawa, Ottawa, Ontario K1H 8M5, Canada; 2Sexual Health Clinic, Ottawa Public Health, Ottawa, Ontario K1N 5P9; 3Division of Infectious Diseases, Ottawa Hospital General Campus, Ottawa, Ontario What you need to know Box 1: Symptoms of syphilis by stage of infection (see fig 1) • Incidence rates of syphilis have increased substantially around the Primary world, mostly affecting men who have sex with men and people infected • Symptoms appear 10-90 days (mean 21 days) after exposure with HIV http://www.bmj.com/ • Main symptom is a <2 cm chancre: • Have a high index of suspicion for syphilis in any sexually active patient – Progresses from a macule to papule to ulcer over 7 days with genital lesions or rashes – Painless, solitary, indurated, clean base (98% specific, 31% sensitive) • Primary syphilis classically presents as a single, painless, indurated genital ulcer (chancre), but this presentation is only 31% sensitive; – On glans, corona, labia, fourchette, or perineum lesions can be painful, multiple, and extra-genital – A third are extragenital in men who have sex with men and in women • Diagnosis is usually based on serology, using a combination of treponemal and non-treponemal tests. Syphilis remains sensitive to • Localised painless adenopathy benzathine penicillin G Secondary on 24 September 2021 by guest.
    [Show full text]
  • Healthcare Providers* Report Immediately by Phone!
    Effective July 2008 COMMUNICABLE AND OTHER INFECTIOUS DISEASES REPORTABLE IN MASSACHUSETTS BY HEALTHCARE PROVIDERS* *The list of reportable diseases is not limited to those designated below and includes only those which are primarily reportable by clinical providers. A full list of reportable diseases in Massachusetts is detailed in 105 CMR 300.100. REPORT IMMEDIATELY BY PHONE! This includes both suspect and confirmed cases. All cases should be reported to your local board of health; if unavailable, call the Massachusetts Department of Public Health: Telephone: (617) 983-6800 Confidential Fax: (617) 983-6813 • REPORT PROMPTLY (WITHIN 1-2 BUSINESS DAYS). This includes both suspect and confirmed cases. All cases should be reported to your local board of health; if unavailable, call the Massachusetts Department of Public Health: Telephone: (617) 983-6800 Confidential Fax: (617) 983-6813 • Anaplasmosis • Leptospirosis Anthrax • Lyme disease Any case of an unusual illness thought to have Measles public health implications • Melioidosis Any cluster/outbreak of illness, including but not Meningitis, bacterial, community acquired limited to foodborne illness • Meningitis, viral (aseptic), and other infectious Botulism (non-bacterial) Brucellosis Meningococcal disease, invasive • Chagas disease (Neisseria meningitidis) • Creutzfeldt-Jakob disease (CJD) and variant CJD Monkeypox or other orthopox virus Diphtheria • Mumps • Ehrlichiosis • Pertussis • Encephalitis, any cause Plague • Food poisoning and toxicity (includes poisoning
    [Show full text]
  • Nonbacterial Pus-Forming Diseases of the Skin Robert Jackson,* M.D., F.R.C.P[C], Ottawa, Ont
    Nonbacterial pus-forming diseases of the skin Robert Jackson,* m.d., f.r.c.p[c], Ottawa, Ont. Summary: The formation of pus as a Things are not always what they seem Fungus result of an inflammatory response Phaedrus to a bacterial infection is well known. North American blastomycosis, so- Not so well appreciated, however, The purpose of this article is to clarify called deep mycosis, can present with a is the fact that many other nonbacterial the clinical significance of the forma¬ verrucous proliferating and papilloma- agents such as certain fungi, viruses tion of pus in various skin diseases. tous plaque in which can be seen, par- and parasites may provoke pus Usually the presence of pus in or on formation in the skin. Also heat, the skin indicates a bacterial infection. Table I.Causes of nonbacterial topical applications, systemically However, by no means is this always pus-forming skin diseases administered drugs and some injected true. From a diagnostic and therapeutic Fungus materials can do likewise. Numerous point of view it is important that physi¬ skin diseases of unknown etiology cians be aware of the nonbacterial such as pustular acne vulgaris, causes of pus-forming skin diseases. North American blastomycosis pustular psoriasis and pustular A few definitions are required. Pus dermatitis herpetiformis can have is a yellowish [green]-white, opaque, lymphangitic sporotrichosis bacteriologically sterile pustules. The somewhat viscid matter (S.O.E.D.). Pus- cervicofacial actinomycosis importance of considering nonbacterial forming diseases are those in which Intermediate causes of pus-forming conditions of pus can be seen macroscopicaily.
    [Show full text]
  • WO 2014/134709 Al 12 September 2014 (12.09.2014) P O P C T
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date WO 2014/134709 Al 12 September 2014 (12.09.2014) P O P C T (51) International Patent Classification: (81) Designated States (unless otherwise indicated, for every A61K 31/05 (2006.01) A61P 31/02 (2006.01) kind of national protection available): AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, (21) International Application Number: BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, PCT/CA20 14/000 174 DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, (22) International Filing Date: HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, 4 March 2014 (04.03.2014) KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, (25) Filing Language: English OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, (26) Publication Language: English SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, (30) Priority Data: ZW. 13/790,91 1 8 March 2013 (08.03.2013) US (84) Designated States (unless otherwise indicated, for every (71) Applicant: LABORATOIRE M2 [CA/CA]; 4005-A, rue kind of regional protection available): ARIPO (BW, GH, de la Garlock, Sherbrooke, Quebec J1L 1W9 (CA). GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, (72) Inventors: LEMIRE, Gaetan; 6505, rue de la fougere, TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, Sherbrooke, Quebec JIN 3W3 (CA).
    [Show full text]
  • 2012 Case Definitions Infectious Disease
    Arizona Department of Health Services Case Definitions for Reportable Communicable Morbidities 2012 TABLE OF CONTENTS Definition of Terms Used in Case Classification .......................................................................................................... 6 Definition of Bi-national Case ............................................................................................................................................. 7 ------------------------------------------------------------------------------------------------------- ............................................... 7 AMEBIASIS ............................................................................................................................................................................. 8 ANTHRAX (β) ......................................................................................................................................................................... 9 ASEPTIC MENINGITIS (viral) ......................................................................................................................................... 11 BASIDIOBOLOMYCOSIS ................................................................................................................................................. 12 BOTULISM, FOODBORNE (β) ....................................................................................................................................... 13 BOTULISM, INFANT (β) ...................................................................................................................................................
    [Show full text]
  • Reportable Disease Surveillance in Virginia, 2013
    Reportable Disease Surveillance in Virginia, 2013 Marissa J. Levine, MD, MPH State Health Commissioner Report Production Team: Division of Surveillance and Investigation, Division of Disease Prevention, Division of Environmental Epidemiology, and Division of Immunization Virginia Department of Health Post Office Box 2448 Richmond, Virginia 23218 www.vdh.virginia.gov ACKNOWLEDGEMENT In addition to the employees of the work units listed below, the Office of Epidemiology would like to acknowledge the contributions of all those engaged in disease surveillance and control activities across the state throughout the year. We appreciate the commitment to public health of all epidemiology staff in local and district health departments and the Regional and Central Offices, as well as the conscientious work of nurses, environmental health specialists, infection preventionists, physicians, laboratory staff, and administrators. These persons report or manage disease surveillance data on an ongoing basis and diligently strive to control morbidity in Virginia. This report would not be possible without the efforts of all those who collect and follow up on morbidity reports. Divisions in the Virginia Department of Health Office of Epidemiology Disease Prevention Telephone: 804-864-7964 Environmental Epidemiology Telephone: 804-864-8182 Immunization Telephone: 804-864-8055 Surveillance and Investigation Telephone: 804-864-8141 TABLE OF CONTENTS INTRODUCTION Introduction ......................................................................................................................................1
    [Show full text]
  • Medical Management of Biological Casualties Handbook
    USAMRIID’s MEDICAL MANAGEMENT OF BIOLOGICAL CASUALTIES HANDBOOK Sixth Edition April 2005 U.S. ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES FORT DETRICK FREDERICK, MARYLAND Emergency Response Numbers National Response Center: 1-800-424-8802 or (for chem/bio hazards & terrorist events) 1-202-267-2675 National Domestic Preparedness Office: 1-202-324-9025 (for civilian use) Domestic Preparedness Chem/Bio Helpline: 1-410-436-4484 or (Edgewood Ops Center – for military use) DSN 584-4484 USAMRIID’s Emergency Response Line: 1-888-872-7443 CDC'S Emergency Response Line: 1-770-488-7100 Handbook Download Site An Adobe Acrobat Reader (pdf file) version of this handbook can be downloaded from the internet at the following url: http://www.usamriid.army.mil USAMRIID’s MEDICAL MANAGEMENT OF BIOLOGICAL CASUALTIES HANDBOOK Sixth Edition April 2005 Lead Editor Lt Col Jon B. Woods, MC, USAF Contributing Editors CAPT Robert G. Darling, MC, USN LTC Zygmunt F. Dembek, MS, USAR Lt Col Bridget K. Carr, MSC, USAF COL Ted J. Cieslak, MC, USA LCDR James V. Lawler, MC, USN MAJ Anthony C. Littrell, MC, USA LTC Mark G. Kortepeter, MC, USA LTC Nelson W. Rebert, MS, USA LTC Scott A. Stanek, MC, USA COL James W. Martin, MC, USA Comments and suggestions are appreciated and should be addressed to: Operational Medicine Department Attn: MCMR-UIM-O U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) Fort Detrick, Maryland 21702-5011 PREFACE TO THE SIXTH EDITION The Medical Management of Biological Casualties Handbook, which has become affectionately known as the "Blue Book," has been enormously successful - far beyond our expectations.
    [Show full text]
  • Rickettsialpox-A Newly Recognized Rickettsial Disease V
    Public Health Reports Vol. 62 * MAY 30, 1947 * No. 22 Printed With the Approval of the Bureau of the Budget as Required by Rule 42 of the Joint-Committee on Printing RICKETTSIALPOX-A NEWLY RECOGNIZED RICKETTSIAL DISEASE V. RECOVERY OF RICKETTSIA AKARI FROM A HOUSE MOUSE (MUS MUSCULUS)1 By ROBERT J. HUEBNER, Senior Assistant Surgeon, WILLIAm L. JELLISON, Parasitologist, CHARLES ARMSTRONG, Medical Director, United States Public Health Service Ricketttia akari, the causative agent of rickettsialpox, was isolated from the blood of persons ill with this disease (1) and from rodent mites Allodermanyssus sanguineus Hirst inhabiting the domicile of ill per- sons (2). This paper describes the isolation of R. akari from a house mouse (Mus musculus) trapped on the same premises-a housing development in the citr of New York where more than 100 cases of rickettsialpox have occurred (3), (4), (5), (6). Approximately 60 house mice were trapped in the basements of this housing development where rodent harborage existed in store rooms and in incinerator ashpits. Engorged mites were occasionally found attached to the mice, the usual site of attachment being the rump. Mites were frequently found inside the box traps after the captured mice were removed. Early attempts to isolate the etiological agent of rickettisalpox from these mice were complicated by the presence of choriomeningitis among them. Twelve successive suspensions of mouse tissue, repre- senting 16 house mice, inoculated intracerebrally into laboratory mice (Swiss strain) and intraperitoneally into guinea pigs resulted in the production of a highly lethal disease in both species which was identified immunologically as choriomeningitis.
    [Show full text]
  • Specialised Services for Infectious Diseases (Adult)
    B07/S/a 2013/14 NHS STANDARD CONTRACT FOR SPECIALISED SERVICES FOR INFECTIOUS DISEASES (ADULT) SECTION B PART 1 - SERVICE SPECIFICATIONS Service Specification B07/S/a No. Service Specialised Services for Infectious Diseases (Adult) Commissioner Lead Provider Lead Period 12 months Date of Review 1. Population Needs 1.1 National/local context and evidence base Incidence and prevalence rates for infectious diseases (ID) are heavily influenced by ethnicity, migration, dispersal, and local factors. In general the burden of infection is greater in urban areas. National surveillance of various infections is undertaken for various diseases including: human immunodeficiency virus (HIV), hepatitis, tuberculosis (TB), sexually transmitted infections, meningo-encephalitis and imported infections. Infectious diseases services are provided by multidisciplinary teams including ID consultants and clinical microbiologists as well as clinicians from many other organ- based and syndrome based specialities. Specialised ID services are currently provided in around 20-25 specialist ID centres in England, including Cutaneous Infections at Kings College Hospital NHS Foundation Trust. Specialist ID centres deal with less common or more serious cases of ID dependent on the specialist diagnostic facilities and clinical expertise available in individual units. These facilities are serviced by teams of doctors with specialist training in ID and microbiology, with support from their colleagues in nursing, radiology and pharmacology. The multidisciplinary ID team co-ordinates a rapid and effective evaluation of the infection and its risk of transmission and provides appropriate diagnostic and medical management on a 24 hour basis. Admissions to the specialised infectious disease services are equivalent to 1 NHS England B07/S/a © NHS Commissioning Board, 2013 The NHS Commissioning Board is now known as NHS England approximately 500 admissions per million population or approximately 25,000 admissions in England per annum.
    [Show full text]